期刊文献+

Setmelanotide的制备工艺改进

Improvements in the Preparation Process of Setmelanotide
原文传递
导出
摘要 采用固相合成法,以Rink Amide MBHA树脂为载体、Fmoc保护的氨基酸为原料、1-羟基苯并三唑(HOBt)/N,N'-二异丙基碳二亚胺(DIC)为缩合试剂、三氟乙酸(TFA)体系为裂解液,按照减肥药setmelanotide(1)的氨基酸序列制得还原型1粗肽,后采用双氧水氧化法环化还原型1,用RP-HPLC技术进行分离纯化,得到纯度98%以上的1精制品,总收率约47%;并对其制备过程中的相关工艺参数进行了探讨和优化,明确了关键工艺参数,为工业化生产奠定基础,也为其他多肽药物研究提供了技术参考。 In this paper,using Rink Amide MBHA resin as the carrier,Fmoc-protected amino acids as the raw materials,1-hydroxybenzotriazole(HOBt)/N,N'-diisopropylcarbodiimide(DIC)as the condensation reagents,and trifluoroacetic acid(TFA)system as the lysis solution,the prototype setmelanotide(1)crude peptide was synthesized by a solid-phase synthesis method according to the amino acid sequence of 1,a weight loss agent.Then the oxidative type 1 was obtained by hydrogen peroxide oxidation method.After separation and purification by the RP-HPLC method,the 1 purified product with a purity of more than 98%was obtained.The total yield of this process was about 47%.The related process parameters in the preparation process of 1 were discussed and optimized.In line with the principle of improving yield and reducing cost,the process parameters of each link were clarified and kept within a controllable range,which laid the foundation for its industrialized large-scale production and also provided a technical reference for other peptide drug researches.
作者 郭晨 冯军 蔡正艳 东圆珍 杨桂英 GUO Chen;FENG Jun;CAI Zhengyan;DONG Yuanzhen;YANG Guiying(School of Life Science and Technology,China Pharmaceutical University,Nanjing 211100;China State Institute of Pharmaceutical Industry,Shanghai 201203;Shanghai Domirui Biotechnology Co.,Ltd.,Shanghai 201203)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2022年第8期1133-1140,共8页 Chinese Journal of Pharmaceuticals
关键词 setmelanotide 固相合成 减肥药 工艺改进 setmelanotide solid-phase synthesis weight loss agent process improvement
  • 相关文献

参考文献2

二级参考文献13

  • 1施溥涛,生物化学杂志,1991年,7卷,691页
  • 2施溥涛,上海医科大学学报,1986年,13卷,161页
  • 3杜雨苍,生物化学与生物物理学报,1964年,4卷,665页
  • 4邢其毅,基础有机化学,1994年,1079页
  • 5Tam J P,J Am Chem Soc,1991年,113卷,6657页
  • 6Coy DH, Murphy WA, Heiman ML. Therapeutic somatostatin analogs: US, 4853371 [P]. 1989-08-01.
  • 7Croxtall JD, Scott LJ. Lanreotide autogel: a review of its use in the management of acromegaly EJ]. Drug, 2008, 68 (5) : 711-723.
  • 8Satin VK, Kent SB, Tam JP, et al. Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction [J]. AnalBiochem, 1981, 117(1): 147-157.
  • 9Annis I, Hargittai B, Barany G. Disulfide bond formation in peptides [J]. Methods Enzymol, 1997, 289: 198-221.
  • 10张琳琳,胡春.醋酸兰瑞肽(lanreotide acetate)[J].中国药物化学杂志,2008,18(1):80-80. 被引量:2

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部